Testing the effectiveness of salpingectomy during adnexectomy
A Performance Study of (opportunistic) Salpingectomy
This study is testing if removing the fallopian tubes during surgery for ovarian issues helps improve the surgery's success for women.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Trial ID | NCT05646680 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the performance quality of opportunistic salpingectomies in women undergoing adnexectomy. Participants scheduled for unilateral or bilateral adnexectomy will have the procedure performed in two steps: first a salpingectomy followed by an oophorectomy. The study will assess the completeness of the salpingectomy and identify factors that may contribute to incomplete resection. The findings may help develop instructional materials to optimize surgical techniques.
Who should consider this trial
Good fit: Ideal candidates are women scheduled for unilateral or bilateral adnexectomy who are Dutch-speaking and able to provide informed consent.
Not a fit: Patients with endometrial cancer, invasive cervical cancer, or those who have had prior pelvic radiotherapy will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical techniques that reduce the risk of ovarian cancer in women.
How similar studies have performed: Other studies have shown promising results regarding the risk-reducing effects of salpingectomy, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients scheduled for uni- or bilateral adnexectomy. (may be in combination with hysterectomy) AND \* competent to act on itself * dutch speaking * signed informed consent Exclusion Criteria: \* Endometrial cancer or invasive cervical cancer * radiotherapy in the pelvis in the medical history * (partial) salpingectomy * Pelvic Inflammatory Disease * Adnexectomy for gender transformation surgery if wish to preserve the ovarian tissue. * Surgery in two steps is not safe to perform * Pregnancy
Where this trial is running
Ghent
- University Hospital — Ghent, Belgium (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.